-
BofA/Merrill Upgrades XRAY To Buy
Wednesday, January 12, 2011 - 9:44am | 49Analysts at BofA/Merrill upgrade DENTSPLY International Inc (NASDAQ: XRAY) from “neutral” to “buy.” The target price for XRAY is set to $40. XRAY shares gained 6.48% to $37.61 in pre-market trading. More Analyst Ratings here
-
15 Low Priced Stocks to watch on the move (CRDC),(FXEN),(RDNT),MOSY) more below
Monday, January 10, 2011 - 6:41pm | 16315 LOW PRICED STOCKS ON THE MOVE,On the move (CRDC),(FXEN),(RDNT),MOSY),(PRWP),(LYSCF),(PSTI),(VSCP),(IMRS),(CERS),(OCZ),(VUTV),(CRME),(INAP),(CHTP)all look good Technically...BIG WINNERS FROM OUR LOW PRICED PICKS LAST NIGHT AND EARLY TODAY INCLUDE (SOL),(ZAGG),(ASTM),(GU)and (EEE) up 25% from...
-
Calls Purchased on Align Technology (ALGN)
Monday, January 10, 2011 - 1:05pm | 135Shares of Align Technology (NASDAQ: ALGN) are lower on the session by 0.35%, currently trading at $19.93. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A...
-
DENTSPLY, Glaxo in Co-branding Pact - Analyst Blog
Monday, January 10, 2011 - 12:01pm | 567Leading dental products maker DENTSPLY International (XRAY) has collaborated with global health care giant GlaxoSmithKline (GSK) to develop co-branded oral care products for use by patients suffering from tooth sensitivity (pain or discomfort), a condition affecting roughly 45 million adults in...
-
DENTSPLY, Glaxo in Co-branding Pact - Analyst Blog
Monday, January 10, 2011 - 11:30am | 567Leading dental products maker DENTSPLY International (XRAY) has collaborated with global health care giant GlaxoSmithKline (GSK) to develop co-branded oral care products for use by patients suffering from tooth sensitivity (pain or discomfort), a condition affecting roughly 45 million adults in...
-
Uroplasty's Third Quarter Fiscal 2011 Revenue Approximately $3.5M
Monday, January 10, 2011 - 8:35am | 70Uroplasty, Inc. (Nasdaq: UPI) announced today that revenue for the third quarter of fiscal 2011 ended December 31, 2010 was approximately $3.5 million. This represents an increase from $3.1 million in revenue for the third quarter a year ago. Uroplasty is providing this update because its...
-
Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Dividend Yield (BAX, BDX, COV, ACL)
Monday, January 10, 2011 - 5:54am | 124Below are the large-cap medical instruments & supply stocks on the NYSE and the NASDAQ in terms of dividend yield. Baxter International Inc (NYSE: BAX) has a dividend yield of 2.50%. BAX's shares closed at $49.41 on Friday. Becton, Dickinson and Company (NYSE: BDX) has a dividend yield of 2.00...
-
Mattel Appoints New COO - Analyst Blog
Friday, January 7, 2011 - 5:03pm | 501California-based company Mattel Inc (MAT), the world's largest manufacturer of toys, has appointed its president of International division Bryan Stockton as its new chief operating officer (COO), effective immediately. Stockton will report to Robert A. Eckert, Mattel's Chairman and chief...
-
Mattel Appoints New COO - Analyst Blog
Friday, January 7, 2011 - 4:30pm | 501California-based company Mattel Inc (MAT), the world's largest manufacturer of toys, has appointed its president of International division Bryan Stockton as its new chief operating officer (COO), effective immediately. Stockton will report to Robert A. Eckert, Mattel's Chairman and chief...
-
Immucor Up 6.1% On Earnings Report (BLUD)
Friday, January 7, 2011 - 2:19pm | 192Shares of Immucor, Inc. (Nasdaq: BLUD) are trading up 6.1% at $20.48 per share during the Friday afternoon trading session. After the market closed on Thursday, the company reported 2nd quarter earnings of 30 cents per share, on revenue of $81.5 million. President and chief executive officer...
-
TranS1 Jumps 63% (TSON)
Friday, January 7, 2011 - 1:20pm | 116Shares of TranS1 Inc. (NASDAQ: TSON) are screaming higher today, currently up by 62.91% and trading at $3.34. There does not appear to be any news out on the company today, but stock volume is running extremely high. Within the first two hours of trading, 2 million shares have trade, which is 77x...
-
Immucor Moves Ahead of Estimates - Analyst Blog
Friday, January 7, 2011 - 1:06pm | 595Immucor Inc. (BLUD) reported an EPS of 30 cents for the second quarter of 2011 (ending in November 2010), surpassing both the Zacks Consensus Estimate of 27 cents and the year-ago quarter's 28 cents. The company reported a 1% decline in revenues to reach $81.5 million. However, revenues were...
-
Immucor Moves Ahead of Estimates - Analyst Blog
Friday, January 7, 2011 - 12:45pm | 595Immucor Inc. (BLUD) reported an EPS of 30 cents for the second quarter of 2011 (ending in November 2010), surpassing both the Zacks Consensus Estimate of 27 cents and the year-ago quarter's 28 cents. The company reported a 1% decline in revenues to reach $81.5 million. However, revenues were...
-
Unconfirmed Rumors Circulate that Align Technology Inc. (ALGN) will be acquired by 3M Co. (MMM) at $30.00 a share
Friday, January 7, 2011 - 11:44am | 32Unconfirmed Rumors Circulate that Align Technology Inc. (ALGN) will be acquired by 3M Co. (MMM) at $30.00 a share...
-
Immucor Rises 8% After Earnings (BLUD)
Friday, January 7, 2011 - 11:35am | 50Immucor (NASDAQ: BLUD) shares have risen more than 8% on Friday in early trade after the company reported better than expected earnings on Thursday after the closing bell. The company reported EPS of $0.30 versus analysts' consensus of $0.27. Year over year revenues were down 1.2%.